Sporting Clube de Braga - Futebol SAD (SCB)
Euronext Lisbon · Portugal · prices in EUR · close of 22 Oct 2026
Key indicators
| Last close | EUR 19.00 |
|---|---|
| 52-week range | 15.00 – 28.80 |
| Return, 1 month / 3 months | −9.5% / −5.0% |
| Return, 1 year / 3 years | +22.6% / +13.1% |
| Trend | Below its 200-day average |
| RSI (14) | 30 |
| Volatility (1 year) | 68.4% |
| Worst drawdown (1 year) | -34.0% |
| Average daily value traded | 0.00M EUR |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Sporting Clube de Braga - Futebol SAD is the football company behind SC Braga, a Portuguese club based in the city of Braga. It runs a professional football team that competes in the Portuguese league and in European club competitions, and it develops youth players through its academy. Its customers are supporters, members and sponsors, and it earns money from matchday tickets, broadcasting, merchandising and player transfers. The club is nicknamed the Arsenalistas and plays its home matches at the Estádio Municipal de Braga.
Sporting Clube de Braga - Futebol SAD trades under the code SCB on the Euronext Lisbon in Portugal, with its price quoted in euros (EUR). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Sporting Clube de Braga - Futebol SAD (SCB) trades on the Euronext Lisbon in Portugal. It last closed at EUR 19.00 on 22 October 2026.
Its price-based Market X-Ray is 41 out of 100 (a weak price profile), ranking 26 of 36 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 22.6% and over the last three months it fell 5.0%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Euronext Lisbon
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 53 · Fair | Mixed trend against its averages. | |
| Above 200-day average | -0.4% | ||
| From 52-week high | -34.0% | ||
| Momentum | 74 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | -5.0% | ||
| 6-month return | 23.4% | ||
| 12-month return, skipping the last month | 35.5% | ||
| Stability (higher is calmer) | 14 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 68.4% | ||
| Worst drawdown, 1 year (smaller is calmer) | -34.0% | ||
| Liquidity | 10 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.00M EUR | ||
| Zero-volume days | 51.7% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 0 |
Strengths
- Momentum: Rising faster than most stocks on this exchange.
Weak spots
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | +0.0% |
|---|---|
| 1 month | −9.5% |
| 3 months | −5.0% |
| 6 months | +23.4% |
| 1 year | +22.6% |
| 3 years | +13.1% |
| 5 years | – |
Signals
| 50-day / 200-day average | 21.33 / 19.09 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.19 |
Technical summary
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Euronext Lisbon; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.